These results overall indicate that mTOR promotes TF expression in EGFR-mut/mTOR-activated lung cancer and GBM cells, which are mediated differentially through mTORC1 and/or mTORC2 in a cellular context-dependent manner. Here, MTOR is linked to lung carcinoma.